Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENOXA vs Lovenox in GI Cancer Surgery
NCT02444572Phase 4Completed
- Sponsor
- Les Laboratoires des Médicaments Stériles
- Start
- Oct 2015
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of enoxaparin in thromboembolism (2 arms), sponsored by Les Laboratoires des Médicaments Stériles. Primary endpoint: Incidence of asymptomatic Deep Venous Thrombosis. Started Oct 2015; status: completed.
02
Drugs
enoxaparin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02444572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444572.